The Leona M. and Harry B. Helmsley Charitable Trust
77
19
32
33
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.3%
1 terminated/withdrawn out of 77 trials
97.1%
+10.5% vs industry average
8%
6 trials in Phase 3/4
33%
11 of 33 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (77)
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Role: collaborator
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)
Role: collaborator
Early Check: Expanded Screening in Newborns
Role: collaborator
Fenofibrate for Prevention of DR Worsening
Role: collaborator
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
Role: collaborator
Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease
Role: collaborator
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Role: collaborator
Expansion of the T1DES Pilot to a Public Hospital
Role: collaborator
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
Role: collaborator
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
Role: collaborator
A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
Role: collaborator
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Role: collaborator
Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe
Role: collaborator
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
Role: collaborator
Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
Role: collaborator
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
Role: collaborator
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Role: collaborator
MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes
Role: collaborator
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
Role: collaborator
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Role: collaborator